Hurdles and Complexities of Codon 13 KRAS Mutations

Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab

(2012) Sabine Tejpar et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status

(2011) Dominik P. Modest et al.   ANTI-CANCER DRUGS

Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution

(2011) B. E. Sylvester et al.   CLINICAL CANCER RESEARCH

Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: Their relationship to KRAS mutational status and disease recurrence

(2011) Petr Kocián et al.   HUMAN IMMUNOLOGY

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

(2010) Wendy De Roock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY